Proteomic profiling of differentially expressed proteins from Bax inhibitor-1 knockout and wild type mice
Bax inhibitor-1 (BI-1) is an anti-apoptotic protein located in the endoplasmic reticulum (ER). The role of BI-1 has been studied in different physiopathological models including ischemia, diabetes, liver regeneration and cancer. However, fundamental knowledge about the effects of BI-1 deletion on th...
Gespeichert in:
Veröffentlicht in: | Molecules and cells 2012, 34(1), , pp.15-23 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Bax inhibitor-1 (BI-1) is an anti-apoptotic protein located in the endoplasmic reticulum (ER). The role of BI-1 has been studied in different physiopathological models including ischemia, diabetes, liver regeneration and cancer. However, fundamental knowledge about the effects of BI-1 deletion on the proteome is lacking. To further explore this protein, we compared the levels of different proteins in bi-1∨-/- and bi-1∨+/+ mouse tissues by two-dimensional electrophoresis (2-DE) and mass spectrometry (MS). In several bi-1∨-/- mice, glucose-regulated protein 75 (GRP75/mortalin/PBP74/mthsp70), peroxiredoxin6 (Prx6) and fumarylacetoacetate hydrolase (FAH) showed a pI shift that could be attributed to post-translational modifications. Seleniumbinding protein 2 (SBP2) and ferritin light chain 1 levels were significantly increased. Phosphatidylethanolaminebinding protein-1 (PEBP-1) was dramatically decreased in bi-1∨-/- mice, which was confirmed by Western blotting. The phosphorylation of GRP75, Prx6 and FAH were compared between bi-1∨+/+ and bi-1∨-/- mice using liver tissue lysates. Of these three proteins, only one exhibited modified phosphorylation; Tyr phosphorylation of Prx6 was increased in bi-1∨-/- mice. Our protein profiling results provide fundamental knowledge about the physiopathological function of BI-1. |
---|---|
ISSN: | 1016-8478 0219-1032 |
DOI: | 10.1007/s10059-012-0001-x |